Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Recursion Pharmaceuticals Inc Cl A
(NQ:
RXRX
)
8.120
+0.280 (+3.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,394,007
Open
7.860
Bid (Size)
8.070 (3)
Ask (Size)
8.150 (1)
Prev. Close
7.840
Today's Range
7.680 - 8.139
52wk Range
4.540 - 16.75
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Millionaire-Maker Biotech Stocks
April 25, 2024
The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.
Via
The Motley Fool
Jim Cramer Says This Energy Stock Is 'Terrific,' Calls Casey's General Stores A 'Winner'
April 24, 2024
Cramer recommends selling PBR, buying EPD, LNG, RXRX, and CASY. Criticisms of AVGO's licensing changes dismissed. PBR and CASY stocks rise.
Via
Benzinga
Performance
YTD
-17.73%
-17.73%
1 Month
-20.16%
-20.16%
3 Month
-16.97%
-16.97%
6 Month
+53.79%
+53.79%
1 Year
+66.05%
+66.05%
More News
Read More
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 24, 2024
Via
Benzinga
Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week
April 23, 2024
Via
Talk Markets
Where Will Recursion Pharmaceuticals Be in 5 Years?
April 17, 2024
Via
The Motley Fool
Analyst Scoreboard: 5 Ratings For Recursion Pharmaceuticals
April 09, 2024
Via
Benzinga
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
April 16, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
April 15, 2024
Via
InvestorPlace
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for April 2024
April 15, 2024
Via
InvestorPlace
The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
April 15, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood's Ark Invest Sells $20M+ Coinbase Shares As Bitcoin Trades Over $70K, Buys Palantir, Sells Nvidia Stock
April 11, 2024
Via
Benzinga
Can Recursion Pharmaceuticals Stock Double in 5 Years? Here's What It Would Take.
April 10, 2024
Via
The Motley Fool
The AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation
April 08, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
AI Surge Ending: Only One Category Was Up This Week
April 06, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is This Under-the-Radar Artificial Intelligence (AI) Stock a Buy?
April 04, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Recursion to Participate in Upcoming Investor Conference
April 02, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
AI Sector Stalling: Only 4 Of 7 Categories Went Up In March
March 31, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
March 26, 2024
Via
Benzinga
Recursion Publishes Annual Environmental, Social and Governance Report
March 26, 2024
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Nvidia's AI Revolution Is Transforming Healthcare with Johnson & Johnson and GE Healthcare Partnerships
March 25, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
New COVID-Like Outbreak 'Matter Of When, Not If,' WHO Director Warns As Scientists Race To Prepare Using Artificial Intelligence
March 18, 2024
Via
Benzinga
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 13, 2024
Via
Benzinga
Nvidia's Secret Weapon Is Not Just Chips But Investing $1.5B In AI's Rising Stars: Report Unveils CEO Jensen Huang's 10-Year Vision
March 11, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Recursion Announces Plans to Open New Office in London
March 11, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Recursion Pharmaceuticals Stock Has 33% Upside, According to 1 Wall Street Analyst
March 07, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.